Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.95 USD
Change Today 0.00 / 0.00%
Volume 0.0
As of 8:10 PM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Georges Benarroch

Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer, Secretary and Director,Kyto BioPharma Inc.
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 5 different industries.

See Board Relationships
As of Fiscal Year 2015


Mr. Georges Benarroch has been the Chief Executive Officer, President and Secretary of Kyto BioPharma Inc. since February 27, 2006 and serves as its Chief Financial Officer and Principal Accounting Officer. Mr. Benarroch has been President of Osprey Gold Corp., since November 15, 2004. He serves as President, Chief Executive Officer and Chairman of the Board of Credifinance Capital Inc. He serves as President and Chief Executive Officer of Credifinance Capital Corp. ...

Read Full Background

Corporate Headquarters*

500 Australian Avenue South
West Palm Beach, Florida 33401

United States

Phone: 416-960-8790
Fax: --

Board Members Memberships*

Chief Executive Officer, President, Principal Financial Officer, Principal Accounting Officer, Secretary and Director


BS 1970
Universite De Montreal, L'
MS 1972
Institut Des Hautes Etudes De Défense Nationale
Doctorate 1974
Université de la Sorbonne - Université de Paris
Faculte de Droit in Toulouse (France)

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Restricted Stock Awards$100,000

Total Compensation*

Other Long Term Compensation$100,000
Total Calculated Compensation$100,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
KBPH:US $0.95 USD 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KYTO BIOPHARMA INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at